Cap. 458 Art. 22Granting of marketing authorisation.

(1) On receipt of the findings and recommendations of the Medicines Authority, or following an appeal or a request for a review by the Medicines Review Board, the Licensing Authority may refuse or otherwise issue a marketing authorisation either as recommended by the Medicines Authority or subject to any such condition or obligation as it may deem necessary.

(2) The decision of the Licensing Authority shall be final and together with the detailed reasons for such decision shall be communicated to the Medicines Review Board, the Medicines Authority and the applicant as necessary.